Global Fosfomycin Calcium Market: Overview
Fosfomycin calcium is a bactericidal
agent with low toxicity levels and low cross-resistance level with other
antibiotics. Known simply as fosfomycin or oral fosfomycin, it acts as
an anti-infective agent by killing sensitive bacteria present in the
affected body part. This substance exhibits high level of activity when
used against gram positive and gram negative bacteria. White or yellow
colored in the powdered form, fosfomycin can be used as an additive in
drinking water and animal feed.
A clear, lucid analysis of the crucial
factors accelerating and inhibiting the growth of the global market for
fosfomycin calcium has been provided in the report. The major market
trends and developments in the competitive landscape have been
discussed, alongside a detailed analysis of the key market vendors and
their business tactics such as partnerships, product innovation, and
mergers. An analysis of the value chain, detailed descriptions of the
key product and application segments, and market attractiveness are also
included in the report.
Global Fosfomycin Calcium Market: Drivers and Restraints
Several studies such as clinical trials
and case reports that incorporate data for patients of all ages, ranging
from children to elderly populace suffering from disorders such as
cystitis, pyelonephritis, gastrointestinal infections, and UTIs have
revealed the efficiency of fosfomycin calcium. It has also been found to
be useful in treating infections caused by several multidrug-resistant
bacteria including penicillin-resistant pneumococci,
vancomycin-resistant enterococci, and methicillin-resistant S.aureus.
Tobramycin is used in combination with fosfomycin calcium in the
treatment of lung infections in patients suffering from cystic fibrosis.
Moreover, when 28 patients with chronic
sinusitis were administered with fosfomycin calcium as a nebulized
treatment, it led to reduction of symptoms in 22 of them. Fosfomycin
calcium can also be a viable alternative replacing fluoroquinolones in
the treatment of chronic bacterial prostatitis, finds a small study that
was presented at Interscience Conference on Antimicrobial Agents and
Chemotherapy held in San Diego during 2015.
In this study conducted by Ilias
Karaiskos, MD, from the Hygeia General Hospital in Greece, a daily
dosage of 3gms for a week, and then 3gms per 48 hours for a 6 week
period was given orally to 20 patients. 85% of these patients, displayed
signs of improved or resolved infection. The positive results of such
research projects could pave the way for further expansion of the market
in the future.
However, side effects such as nausea,
dizziness, and gastrointestinal disturbances incurred by fosfomycin
calcium-drugs might inhibit the growth of the global market for
fosfomycin calcium. Nonetheless, the expansion of the market is assured
by the ceaseless efforts of the market players who are attempting to
explore the emerging markets.
Global Fosfomycin Calcium Market: Regional Outlook
Asia Pacific, being the fastest growing
region, promises considerable growth opportunities. India and China,
exhibiting high demand for fosfomycin calcium are expected emerge as the
key contributors to revenue generated by the Asia Pacific market.
Countries such as Brazil, Germany, Japan, South Africa, France, and
Spain have been using fosfomycin calcium on a large scale. North
American region is also likely to register significant growth, thanks to
the adoption of fosfomycin calcium in the treatment of uncomplicated
urinary tract infection (UTI). Europe has also been displaying
increasing demand for fosfomycin calcium, which is sold for oral use
under different brand names.
Companies mentioned in the research report
FarmaSino Pharmaceuticals (Jiangsu) Co.,
Ltd., Ercros S.A., AdvaCare Pharma, China Sinopharm International
Shanghai Co., Ltd., Serendex Pharmaceuticals A/S, Northeast
Pharmaceutical Group Co., Ltd., SINTOFARM FARMACEUTICI S.p.A., and
Mingshui Fukang Chemical Co., Ltd. are some of the major companies
operating in the global market for fosfomycin calcium.
No comments:
Post a Comment